Contract Pharmacal Corp.
Contract Pharmacal Corp. (CPC), headquartered in the United States, is a leading player in the pharmaceutical and nutraceutical industries. Founded in 1971, CPC has established itself as a trusted contract manufacturer, specialising in the development and production of dietary supplements, over-the-counter medications, and prescription pharmaceuticals. With a commitment to quality and innovation, CPC offers a diverse range of products, including tablets, capsules, and powders, tailored to meet the unique needs of its clients. The company’s state-of-the-art facilities and adherence to stringent regulatory standards position it as a reliable partner in the health and wellness sector. Recognised for its exceptional service and expertise, Contract Pharmacal Corp. continues to thrive, serving a broad clientele across North America and beyond, while maintaining a strong reputation for excellence in product formulation and manufacturing.
DitchCarbon Score
How does Contract Pharmacal Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Contract Pharmacal Corp.'s score of 4 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Contract Pharmacal Corp.'s reported carbon emissions
Contract Pharmacal Corp., headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. Additionally, the company has not outlined any formal reduction targets or commitments to climate initiatives, such as Science-Based Targets Initiative (SBTi) goals or other climate pledges. In the absence of specific emissions data or reduction initiatives, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and carbon footprint reduction. This trend highlights the importance of transparency and accountability in addressing climate change. As the industry evolves, it is anticipated that Contract Pharmacal Corp. may adopt similar practices to enhance its environmental performance and align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Contract Pharmacal Corp. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
